Abstract

Secondary metabolism in the model fungus Aspergillus nidulans is controlled by the conserved global regulator VeA, which also governs morphological differentiation. Among the secondary metabolites regulated by VeA is the mycotoxin sterigmatocystin (ST). The presence of VeA is necessary for the biosynthesis of this carcinogenic compound. We identified a revertant mutant able to synthesize ST intermediates in the absence of VeA. The point mutation occurred at the coding region of a gene encoding a novel putative C2H2 zinc finger domain transcription factor that we denominated mtfA. The A. nidulans mtfA gene product localizes at nuclei independently of the illumination regime. Deletion of the mtfA gene restores mycotoxin biosynthesis in the absence of veA, but drastically reduced mycotoxin production when mtfA gene expression was altered, by deletion or overexpression, in A. nidulans strains with a veA wild-type allele. Our study revealed that mtfA regulates ST production by affecting the expression of the specific ST gene cluster activator aflR. Importantly, mtfA is also a regulator of other secondary metabolism gene clusters, such as genes responsible for the synthesis of terrequinone and penicillin. As in the case of ST, deletion or overexpression of mtfA was also detrimental for the expression of terrequinone genes. Deletion of mtfA also decreased the expression of the genes in the penicillin gene cluster, reducing penicillin production. However, in this case, over-expression of mtfA enhanced the transcription of penicillin genes, increasing penicillin production more than 5 fold with respect to the control. Importantly, in addition to its effect on secondary metabolism, mtfA also affects asexual and sexual development in A. nidulans. Deletion of mtfA results in a reduction of conidiation and sexual stage. We found mtfA putative orthologs conserved in other fungal species.

Highlights

  • Fungal species produce numerous secondary metabolites [1,2,3], including compounds with detrimental effects, such as mycotoxins [4], capable of causing disease and death in humans and other animals [4,5]

  • Classical genetics analysis revealed that these revertant mutants (RM) belong to different linkage groups

  • The mutation in RM7 was recessive and the specific affected locus was found by complementation of RM7-R2 with an A. nidulans genomic library.Several positive transformants showing wild-type phenotype were obtained

Read more

Summary

Introduction

Fungal species produce numerous secondary metabolites [1,2,3], including compounds with detrimental effects, such as mycotoxins [4], capable of causing disease and death in humans and other animals [4,5]. The range of secondary metabolites produced by A. nidulans includes bioactive compounds with demonstrated beneficial effects and applications for medical treatments, including antibiotics, such as the beta-lactam penicillin (PN) [13,14], or anti-tumoral metabolites such as terrequinone [15,16], with potential direct application in the medical field. In both cases the genes involved in the synthesis of these compounds are found clustered [16,17]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call